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ORIGINAL ARTICLE EPIDEMIOLOGYA validation of the Danish microbiology database (MiBa) and incidence
rate of Actinotignum schaalii (Actinobaculum schaalii) bacteraemia in
DenmarkS. Bank1, K. M. Søby1, L. H. Kristensen1, M. Voldstedlund2 and J. Prag1
1) Department of Microbiology Viborg-Herning, Viborg and 2) Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, DenmarkAbstractActinotignum schaalii (former named Actinobaculum schaalii) can cause urinary tract infections (UTIs) and bacteraemia, mainly in the elderly.
A. schaalii is difﬁcult to identify with conventional biochemical tests, and it is often overlooked if the urine is only cultured in ambient air.
The aim of this study was to validate data from the nationwide Danish microbiology database (MiBa) with data from the laboratory
information system (LIS) at the local department of microbiology in Viborg-Herning, and to evaluate the incidence rate of bacteraemia
caused by A. schaalii in Denmark by using data from the MiBa. All departments of microbiology in Denmark report data to the MiBa. All
microbiological samples with A. schaalii in Denmark were extracted for a period of 5 years from the MiBa and from the local LISs. All data
obtained from our local LIS were also found in the MiBa, except for data on real-time PCR, which were not registered, owing to missing
ID codes in the MiBa. From 2010 to 2014, there was a signiﬁcant increase in the incidence rate of blood cultures with A. schaalii, from 1.8
to 6.8 cases per million, which was probably due to coincident implementation of matrix-assisted laser desorption ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS) in routine diagnostics. We found that A. schaalii caused bacteraemia and UTIs mainly in the elderly.
In conclusion, the MiBa can be a useful source of nationwide microbiological data in Denmark. Our results suggest that the incidence rate
of A. schaalii as a cause of bacteraemia has been underestimated, and that culture of urine in CO2 can improve the detection of A. schaalii.
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E-mail: stb@mb.au.dkIntroductionActinobaculum schaalii has recently been renamed Actinotignum
schaalii [1]. A. schaalii can cause bacteraemia and urinary
tract infections (UTIs), mainly in the elderly [2–5]. Further-
more, toddlers seem to be at risk for UTI caused by A. schaalii
[6,7].Clinical Microbiology and Infection © 2015 European Society of CA. schaalii is a Gram-positive capnophilic rod, resembling the
commensal coryneform bacteria on the skin and mucosa. It is
difﬁcult to identify with conventional biochemical tests, and
identiﬁcation often requires molecular techniques (PCR) or
matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry (MS) [3,4,8,9]. A. schaalii is
therefore often overlooked, and is mostly found as mono-
cultures after 2–3 days of incubation in CO2 [3,4,10]. A. schaalii
is resistant to trimethoprim and ciproﬂoxacin, but susceptible
to β-lactams [4].
Since 2010, all routine culture results have been registered
both in the respective local laboratory information systems
(LISs) and centrally in the nationwide Danish microbiology
database (MiBa) [11]. Like other nationwide microbiologicalClin Microbiol Infect 2015; 21: 1097.e1–1097.e4
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ological studies, for surveillance of resistant bacteria, and for
identifying patients for genetic studies [12]. A validation of the
MiBa with data from a local LIS will further strengthen the MiBa
as a reliable source of nationwide microbiological data in
Denmark.
After validation of the MiBa, the aim of the study was to
estimate the incidence rate of bacteraemia caused by A. schaalii
in Denmark by using data from the MiBa.Materials and methodsData collection
In Denmark, all clinical microbiology laboratories are public,
and serve both hospitals and general practitioners in their up-
take area. Since 2010, they have all reported data to the MiBa.
All microbiological reports showing positivity for A. schaalii
were extracted for a period of 5 years from 1 January 2010,
from the MiBa and the local LIS in Viborg-Herning, Middle-
West, which is part of Central Jutland, with an uptake popu-
lation of approximately 450 000 persons. The data from the
MiBa and the local LIS included sample date, age, sex, and in-
formation on sample material, with type of specimen and sus-
ceptibility results.
In addition, clinical information was obtained from the clin-
ical records from patients with a blood culture positive for
A. schaalii registered in our local LIS.
Culture
Most departments of microbiology in Denmark culture urine in
ambient air without CO2 at 35°C for 1 day. Uniquely, in the
department of microbiology in Viborg-Herning, urine was
cultured on 5% Columbia sheep blood agar (Becton Dickinson,
Heidelberg, Germany) in ambient air with 5% CO2 for 2 days at
35°C until 2011.
Identiﬁcation
A. schaalii was detected with biochemical tests and identiﬁed by
16S rRNA sequencing, MALDI-TOF MS, or our in house real-
time PCR.
MALDI-TOF MS
Most departments of microbiology introduced MALDI-TOF MS
during the period from 2010 to 2014. To examine what effect
the introduction of MALDI-TOF MS had on the identiﬁcation of
A. schaalii, the average number of samples per year before and
after MALDI-TOF MS was introduced in the local laboratories
was used. As only the year, and not the exact date, for MALDI-
TOF MS introduction was known for most laboratoriesClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect(personal communication), the data from the year of intro-
duction of MALDI-TOF MS were omitted. Only data from the
years before and after MALDI-TOF MS introduction were
included.
Statistical analysis
Specimen duplicates from the same year with the same sample
type, e.g. blood, urine, abscesses, or other, were excluded.
Incidence rates were calculated by using information on pop-
ulation size from www.statistikbanken.dk. A chi-square test was
used to compare incidence rates of blood cultures with
A. schaalii. Statistical analyses and handling of the extracted data
were performed with STATA version 11 (STATA Corp.,
College Station, TX, USA).ResultsAll Danish microbiology departments reported to the MiBa.
Cases of A. schaalii identiﬁed with our real-time PCR were
extracted from our local LIS in Viborg-Herning, but were
initially not found in the MiBa, owing to missing ID codes in the
MiBa. The MiBa was then updated to include A. schaalii identi-
ﬁed with real-time PCR, and the new, updated data extracted
from the MiBa were used in this study. No other differences
were found.
The data from the MiBa showed that people aged 55
years had the highest risk of bacteraemia with A. schaalii, with
an incidence rate of 10.9 cases per million per year (94 cases
per 1.7 million inhabitants per 5 years). The incidence rate of
urine cultures with A. schaalii per million per year was highest
(5.0; six cases per 0.24 million inhabitants per 5 years) for
both toddlers aged 3 years, (13.4; 115 cases per 1.7 million
inhabitants per 5 years) and for people aged 55 years
(Table 1).
There was an increase in the incidence rate of blood cultures
with A. schaalii from 1.8 to 6.8 (ten and 38 cases per 5.6 million
inhabitants, respectively) cases per million from 2010 to 2014
(p < 0.0001). There was also an increase in the incidence rate of
A. schaalii found in abscesses, pus and tissue from 2010 to 2014,
and here also the highest incidence rate was found in people
aged 55 years (Tables 1 and 2).
The average numbers of samples per year before and after
MALDI-TOF MS was introduced in the local laboratories were
10.5 and 25.0 for blood cultures (p < 0.05), 31.5 and 15.8 for
urine cultures (p < 0.05), 4.3 and 39.7 for abscesses (p < 0.05),
and 3.5 and 11.0 (p < 0.05) for other locations, respectively.
This suggests an increase in the identiﬁcation of A. schaalii in all
sample types after the introduction of MALDI-TOF MS, except
for urine samples.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1097.e1–1097.e4
TABLE 1. Number of specimens with Actinotignum schaalii by age in Denmark, 2010-2014a
Age (years)
0–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80–89 ‡90 Total
Blood culture (incidence per million per year)b 0 (0) 0 (0) 0 (0) 1 (0.3) 2 (0.5) 5 (1.4) 15 (4.3) 29 (13.3) 33 (34.1) 13 (63.6) 98 (3.5)
Urine 10 4 0 6 6 16 31 33 33 8 147
Abscess, pus, tissuec 2 5 14 19 26 31 24 13 11 4 149
Unspeciﬁed cultures 4 4 4 5 3 11 10 8 5 1 55
Total 16 13 18 31 37 63 80 83 82 26 449
aThe numbers were based on data extracted from the national Danish microbiology database (MiBa).
bThe incidence was based on population data from http://statistikbanken.dk.
cA. schaalii was found in 25 abscess, 101 pus and 23 tissue samples.
CMI Bank et al. Incidence rate of A. schaalii bacteraemia in Denmark 1097.e3Many more urine cultures with A. schaalii were observed in
Central Jutland than in other regions of Denmark (Table 3).
Until 2011, urine was cultured in 5% CO2 in Viborg-Herning,
but, during 2011, independently but coincident with introduc-
tion of MALDI-TOF MS, culture of urine in 5% CO2 ceased.
This resulted in a decrease in the detection of A. schaalii in urine
cultures from 35 in 2010 to 25, 19, seven and four in 2011,
2012, 2013, and 2014, respectively (p < 0.05). When data from
Viborg-Herning were omitted, the average number of samples
per year before and after the introduction of MALDI-TOF MS
changed to 1.0 and 10.3 for urine (p < 0.05).
Ten patients had a blood culture with A. schaalii in Viborg-
Herning from 2010 to 2014. The patients had elevated C-
reactive protein levels (median, 150 mg/L; range, 25–333 mg/L),
and the median age was 79 years (range, 52–88 years). Seven of
the ten patients were males. Six patients had urosepsis, and ﬁve
patients had predisposing urogenital illnesses (Table 4).DiscussionThis is the ﬁrst nationwide study of A. schaalii. The comparison
of data extracted from the MiBa and the local LIS showed that
validation with data from a random sample was important to
make the data complete. After the updating and validation of
the MiBa, our study supports the idea that the MiBa containsTABLE 2. Number of specimens with Actinotignum schaalii by
calendar year in Denmark, 2010–2014a
Year
2010 2011 2012 2013 2014 Total
Blood culture 10 14 17 19 38 98
Urine 38 34 27 25 23 147
Abscess, pus, tissue 7 7 26 55 54 149
Unspeciﬁed cultures 3 7 13 11 21 55
Total 58 62 83 110 136 449
aThe numbers were based on data extracted from the national Danish microbiology
database (MiBa).
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infecomplete nationwide data for A. schaalii in Denmark and that
the MiBa can be used as a reliable source of nationwide
microbiological data in Denmark [11].
Our data conﬁrms that A. schaalii causes bacteraemia mainly
in the elderly, predominantly males, many had predisposing
urogenital illnesses and it causes UTI in both elderly and tod-
dlers, which is in accordance with previous studies [2–5]. As
the clinical characteristics of the ten patients with bacteraemia
from Viborg-Herning resemble earlier ﬁndings, it is likely that
these ten patients were representative of all Danish patients.
Furthermore, the clinical data suggest that A. schaalii is often
found in polymicrobial infections in urine, in line with other
studies [3,4,8].
The signiﬁcant increase in the incidence rate of blood cul-
tures with A. schaalii since 2010 suggests that A. schaalii has been
underestimated as a cause of bacteraemia. The unexpected
increase in the incidence rate of A. schaalii in abscesses, pus and
tissue also suggests that A. schaalii has been overlooked as a
cause of abscesses. MALDI-TOF MS is a powerful tool for
identifying rare bacterial species [9,12]. The implementation of
MALDI-TOF MS in routine diagnostics in most microbiological
departments in Denmark has made it much easier to identify
A. schaalii. Our results suggest that the introduction of MALDI-
TOF MS has increased the identiﬁcation of A. schaalii by more
than two-fold, even in blood. Even though MALDI-TOF MS is a
powerful tool, our results from Viborg-Herning show that, inTABLE 3. Number of specimens (and incidence per million
per year) with Actinotignum schaalii by regional location in
Denmark, 2010–2014a
Regional location
(million inhabitants)
Blood culture
(incidence) Urine
Abscess,
pus, tissue
Unspeciﬁed
cultures
Copenhagen (1.7) 41 (4.8) 27 89 25
Zealand (0.7) 14 (4.0) 5 23 9
South Denmark (1.2) 19 (3.2) 10 4 1
Central Jutland (1.3) 17 (2.6) 93 25 17
North Jutland (0.6) 7 (2.3) 12 8 3
Denmark (5.6) 98 (3.6) 147 149 55
aThe numbers were based on data extracted from the national Danish microbiology
database (MiBa).
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TABLE 4. Clinical characteristics of ten patients from the department of microbiology Viborg-Herning with a positive blood
culture with Actinotignum schaalii, 2010–2014
Gender
Age
(years)
CRP
(mg/L) Clinical presentation Other complications Pathogens in the urine
Other pathogens in the
blood
Male 86 333 Urosepsis — A. schaalii, Citrobacter braakii, Pseudomonas aeruginosa,
Enterococcus faecalis
—
Female 60 25 Urosepsis Accidental medicine
poisoning
A. schaalii, Escherichia coli, Aerococcus urinae —
Male 73 — Urosepsis — Non-haemolytic Streptococcus Peptostreptococcus species
Female 52 248 Urosepsis and nephrostomy Colorectal cancer None Peptostreptococcus
asaccharolyticus
Male 75 92 Urosepsis and hydronephrosis — A. schaalii —
Male 82 228 Urosepsis and hydronephrosis Prostate cancer A. schaalii, Enterococcus faecalis —
Male 88 136 Urinary retention Epididymitis Enterobacter cloacae —
Male 67 108 Urinary retention Diabetes and lichen
sclerosus (penis)
None —
Male 82 199 No symptoms of urinary tract
infection
Parkinsonism A. schaalii, Aerococcus urinae Aerococcus urinae
Female 83 163 Acute cystitis — A. schaalii —
CRP, C-reactive protein.
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tures, incubation in CO2 is paramount. We ﬁnd it reasonable to
expect that comparable incidence rates of A. schaalii infections
will be observed in other western countries in Europe, the
USA, and Canada [13].
We recommend that both the local departments of micro-
biology and the general practitioners should be aware of
A. schaalii as a possible cause of UTI. It is optimal to change
routines and incubate all urine cultures in 5% CO2 for 48 h.
However, if this is not possible, then special attention should be
directed to patients treated with trimethoprim or ciproﬂoxacin
without effect, and to patients with unexplained chronic UTIs.
When the initial wet smear microscopy reveals bacterial
coryneform rods and leukocytes, but culture shows no growth
under aerobic cultivation conditions, we recommend that the
urine should be incubated in 5% CO2 and/or aerobically on 5%
blood agar plates for at least 48 h [14].Transparency declarationThe authors declare that they have no conﬂicts of interest.References[1] Yassin AF, Sproer C, Pukall R, Sylvester M, Siering C, Schumann P.
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